1967
DOI: 10.1111/j.1749-6632.1967.tb13708.x
|View full text |Cite
|
Sign up to set email alerts
|

Distribution of Nicotine in the Central Nervous System

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
21
0

Year Published

1972
1972
1995
1995

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 72 publications
(22 citation statements)
references
References 7 publications
1
21
0
Order By: Relevance
“…These investigators suggested that the high nicotine concentration ratio resulted from some factor other than the pH gradient, for example, selective dissolution in non-aqueous components (reflecting its lipid solubility) or selective intracellular binding. Neither seems very likely in ganglia, because (a) autoradiographs have shown that nicotine tends to be excluded from, rather than concentrated in, such lipid elements as myelin (Schmiterlow, Hansson, Andersson, Appelgren & Hoffmann, 1967;Brown et al, 1969a) and (b) the uptake of nicotine by ganglion cells is proportional to the external concentration over a wide concentration range, which argues against a finite number of binding sites (Brown et al, 1971). …”
Section: Uptake Of 3h-nicotinementioning
confidence: 99%
“…These investigators suggested that the high nicotine concentration ratio resulted from some factor other than the pH gradient, for example, selective dissolution in non-aqueous components (reflecting its lipid solubility) or selective intracellular binding. Neither seems very likely in ganglia, because (a) autoradiographs have shown that nicotine tends to be excluded from, rather than concentrated in, such lipid elements as myelin (Schmiterlow, Hansson, Andersson, Appelgren & Hoffmann, 1967;Brown et al, 1969a) and (b) the uptake of nicotine by ganglion cells is proportional to the external concentration over a wide concentration range, which argues against a finite number of binding sites (Brown et al, 1971). …”
Section: Uptake Of 3h-nicotinementioning
confidence: 99%
“…Uptake is lowered in vivo by pentobarbital anesthesia, and is reduced in brain slices by lowering temperature. 16 -22 " 27 Most of the 3 H in the brain at 240 sec is associated with 3 H-nicotine; less than 3% is due to 3 H-cotinine, a metabolic derivative of 3 H-nicotine that is produced in liver and kidney and appears in blood about 180 sec after an intravenous injection, but is poorly permeable at the blood-brain barrier. 26 -…”
Section: Mathematical Analysis Of Datamentioning
confidence: 99%
“…4 -34~36 If 3 H-nicotine binding by brain is a measure of density of cells and nerve endings, then short-term experiments (50 sec or less) with nicotine might be used to estimate LCBF and longterm experiments (5 min or more) to estimate density of cells and nerve endings. 16 -22~27 Nicotine, when incorporating the positron emitter 13 N, might also be used in man to measure regional blood flow by means of emission computed tomography.…”
Section: Smentioning
confidence: 99%
See 1 more Smart Citation
“…The pharma cokinetics of nicotine have been widely stud ied in humans [1-6], Its plasma half-time is approximately 2 h in humans. The lipoid sol ubility of nicotine and its penetration of the blood-brain barrier [7], its distribution in the central nervous system [8], its distribution kinetics [9]. and its metabolism in liver [10] and lung [11] have also been studied in exper imental animals.…”
mentioning
confidence: 99%